Senna and Docusate Sodium is a Oral Tablet, Film Coated in the Human Otc Drug category. It is labeled and distributed by Sunrise Pharmaceutical Inc. The primary component is Docusate Sodium; Sennosides.
| Product ID | 11534-090_dda29277-e3fb-4563-a038-53838c055ff4 |
| NDC | 11534-090 |
| Product Type | Human Otc Drug |
| Proprietary Name | Senna and Docusate Sodium |
| Generic Name | Senna And Docusate Sodium |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2007-07-26 |
| Marketing Category | OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL |
| Application Number | part334 |
| Labeler Name | Sunrise Pharmaceutical Inc |
| Substance Name | DOCUSATE SODIUM; SENNOSIDES |
| Active Ingredient Strength | 50 mg/1; mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2007-07-26 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC monograph not final |
| Application Number | part334 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-07-26 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | OTC monograph not final |
| Application Number | part334 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-07-26 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| DOCUSATE SODIUM | 50 mg/1 |
| SPL SET ID: | 56c38795-7b35-43bf-900e-07df84d27c14 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 11534-090 | Senna and Docusate Sodium | Senna and Docusate Sodium |
| 11534-134 | Senna and Docusate Sodium | Senna and Docusate Sodium |
| 0603-0149 | DocQLax | senna and docusate sodium |
| 0603-0283 | SennaLax-S | senna and docusate sodium |
| 55700-365 | SennaLax-S | senna and docusate sodium |
| 68788-0848 | SennaLax-S | senna and docusate sodium |